Home | Welcome to Contract Pharma   
Last Updated Thursday, October 23 2014
Print RSS Feed

Breaking News

May 9, 2014
Will use CRISPR/Cas9 gene editing system for research applications   Read More »
May 9, 2014
Will provide early stage preclinical to commercial production  Read More »
May 9, 2014
Will combine adaptive trial capabilities with ICON’s technology platforms  Read More »
May 9, 2014
Aims to develop new experimental cancer models  Read More »
May 7, 2014
Will align Pharmorphix and BioTools for comprehensive chiral technology services  Read More »
May 7, 2014
Plans further investments in promising start-ups   Read More »
May 7, 2014
Aims to improve treatments for multi-drug resistant bacterial infections  Read More »
May 7, 2014
Andreasson brings extensive biopharma ops experience   Read More »
May 7, 2014
Adds early phase development and CMC services  Read More »
May 7, 2014
Smith to develop scientific excellence and enhance R&D platforms  Read More »
May 7, 2014
Specialty pharma sales up 10% in the quarter  Read More »
May 6, 2014
Sommerville to support U.S. regulatory activities for epilepsy programs  Read More »
May 6, 2014
Evotec will employ its drug discovery platform to identify a clinical candidate  Read More »
May 6, 2014
Providers need to develop integrated marketing plans   Read More »
May 6, 2014
Decline in royalties impacts results  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On